Product correctly added to cart.

discount label
(1R,6S)-2,8-Diazabicyclo[4.3.0]nonane
View 3D

Biosynth logo

(1R,6S)-2,8-Diazabicyclo[4.3.0]nonane

CAS: 169533-56-6

Ref. 3D-UGA53356

25mgTo inquire
50mgTo inquire
100mgTo inquire
Estimated delivery in United States, on Wednesday 8 Jan 2025

Product Information

Name:
(1R,6S)-2,8-Diazabicyclo[4.3.0]nonane
Description:

2,8-Diazabicyclo[4.3.0]nonane is a research and development (R&D) impurity standard with a purity of ≥98%. This product has CAS number 169533-56-6 and is classified as a synthetic drug product. 2,8-Diazabicyclo[4.3.0]nonane can be used for the synthesis of drugs and pharmaceuticals, as well as for the study of metabolic pathways in vitro and in vivo. It is also an analytical standard for HPLC analysis, which can be used to measure the concentration of metabolites in urine or blood samples. 2,8-Diazabicyclo[4.3.0]nonane has been shown to inhibit the metabolism of a variety of compounds that are metabolized by cytochrome P450 enzymes such as CYP1A2 and CYP2C9, which are important enzymes involved in drug metabolism processes.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
126.20 g/mol
Formula:
C7H14N2
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-UGA53356 (1R,6S)-2,8-Diazabicyclo[4.3.0]nonane

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".